Jasmeer Preet Chhatwal, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 109 | 2024 | 8599 | 5.520 |
Why?
|
Amyloid beta-Peptides | 71 | 2024 | 3839 | 3.870 |
Why?
|
tau Proteins | 45 | 2024 | 2095 | 3.590 |
Why?
|
Positron-Emission Tomography | 60 | 2024 | 6485 | 1.600 |
Why?
|
Brain | 58 | 2024 | 27112 | 1.370 |
Why?
|
Nerve Net | 12 | 2024 | 2290 | 1.320 |
Why?
|
Presenilin-1 | 11 | 2024 | 660 | 1.020 |
Why?
|
Aniline Compounds | 20 | 2021 | 1069 | 0.920 |
Why?
|
Aging | 17 | 2024 | 8708 | 0.920 |
Why?
|
Apolipoproteins E | 8 | 2024 | 1444 | 0.910 |
Why?
|
Thiazoles | 20 | 2021 | 1517 | 0.800 |
Why?
|
Carbolines | 5 | 2019 | 296 | 0.780 |
Why?
|
Extinction, Psychological | 6 | 2008 | 371 | 0.750 |
Why?
|
Presenilin-2 | 6 | 2018 | 95 | 0.750 |
Why?
|
Amyloidosis | 6 | 2024 | 817 | 0.750 |
Why?
|
Magnetic Resonance Imaging | 50 | 2024 | 36426 | 0.740 |
Why?
|
Heterozygote | 11 | 2023 | 2787 | 0.730 |
Why?
|
Amygdala | 6 | 2009 | 1354 | 0.680 |
Why?
|
Scopolamine | 1 | 2019 | 93 | 0.650 |
Why?
|
Nerve Degeneration | 2 | 2020 | 748 | 0.640 |
Why?
|
Longitudinal Studies | 27 | 2024 | 14605 | 0.620 |
Why?
|
Cholinergic Antagonists | 1 | 2019 | 168 | 0.620 |
Why?
|
Temporal Lobe | 7 | 2019 | 1695 | 0.610 |
Why?
|
Down Syndrome | 5 | 2024 | 901 | 0.610 |
Why?
|
Memory | 3 | 2019 | 2188 | 0.600 |
Why?
|
Brain-Derived Neurotrophic Factor | 5 | 2019 | 602 | 0.590 |
Why?
|
Amyloid beta-Protein Precursor | 8 | 2022 | 1111 | 0.570 |
Why?
|
Cognition | 14 | 2024 | 6990 | 0.530 |
Why?
|
Atrophy | 13 | 2024 | 1633 | 0.530 |
Why?
|
Fear | 7 | 2008 | 1476 | 0.500 |
Why?
|
Disease Progression | 15 | 2024 | 13506 | 0.470 |
Why?
|
Aged | 67 | 2024 | 169289 | 0.460 |
Why?
|
Cholecystokinin | 3 | 2009 | 117 | 0.450 |
Why?
|
Amyloid | 10 | 2024 | 841 | 0.440 |
Why?
|
Cerebral Amyloid Angiopathy | 4 | 2023 | 895 | 0.440 |
Why?
|
Neurofilament Proteins | 4 | 2024 | 336 | 0.430 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3492 | 0.430 |
Why?
|
Neural Pathways | 3 | 2019 | 3058 | 0.410 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1474 | 0.380 |
Why?
|
Apolipoprotein E4 | 5 | 2019 | 708 | 0.380 |
Why?
|
Male | 92 | 2024 | 360804 | 0.380 |
Why?
|
Aged, 80 and over | 35 | 2024 | 58976 | 0.370 |
Why?
|
Hippocampus | 10 | 2021 | 3766 | 0.370 |
Why?
|
Cerebral Cortex | 7 | 2023 | 5777 | 0.360 |
Why?
|
Lentivirus | 4 | 2009 | 508 | 0.360 |
Why?
|
Humans | 130 | 2024 | 761504 | 0.360 |
Why?
|
Cross-Sectional Studies | 28 | 2024 | 26125 | 0.360 |
Why?
|
Brain Mapping | 7 | 2021 | 6630 | 0.350 |
Why?
|
Genotype | 2 | 2024 | 12990 | 0.350 |
Why?
|
Plaque, Amyloid | 3 | 2024 | 760 | 0.350 |
Why?
|
Entorhinal Cortex | 4 | 2023 | 287 | 0.340 |
Why?
|
Receptor, Cannabinoid, CB1 | 2 | 2008 | 137 | 0.340 |
Why?
|
Cerebral Amyloid Angiopathy, Familial | 2 | 2020 | 54 | 0.340 |
Why?
|
Female | 84 | 2024 | 392644 | 0.330 |
Why?
|
Receptor, Cholecystokinin B | 1 | 2008 | 6 | 0.320 |
Why?
|
Mutation | 22 | 2024 | 30052 | 0.290 |
Why?
|
Endocannabinoids | 1 | 2008 | 111 | 0.290 |
Why?
|
Receptors, Cannabinoid | 1 | 2007 | 43 | 0.280 |
Why?
|
Conditioning, Classical | 2 | 2007 | 368 | 0.280 |
Why?
|
Parietal Lobe | 2 | 2024 | 852 | 0.270 |
Why?
|
Peptide Fragments | 8 | 2021 | 5112 | 0.270 |
Why?
|
Lewy Bodies | 2 | 2024 | 145 | 0.260 |
Why?
|
Genes, Dominant | 3 | 2018 | 852 | 0.250 |
Why?
|
Amyloidogenic Proteins | 5 | 2023 | 151 | 0.250 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15500 | 0.240 |
Why?
|
Cognitive Reserve | 2 | 2024 | 92 | 0.240 |
Why?
|
Frontal Lobe | 2 | 2024 | 1420 | 0.240 |
Why?
|
Age of Onset | 4 | 2024 | 3305 | 0.230 |
Why?
|
Awareness | 2 | 2020 | 648 | 0.230 |
Why?
|
Fluorodeoxyglucose F18 | 5 | 2021 | 2010 | 0.230 |
Why?
|
Cognition Disorders | 1 | 2018 | 3979 | 0.230 |
Why?
|
Middle Aged | 46 | 2024 | 220895 | 0.220 |
Why?
|
Ethylene Glycols | 3 | 2019 | 190 | 0.220 |
Why?
|
Meninges | 2 | 2022 | 198 | 0.210 |
Why?
|
Arthrogryposis | 1 | 2023 | 68 | 0.210 |
Why?
|
Proteomics | 4 | 2023 | 3849 | 0.210 |
Why?
|
Memory Disorders | 3 | 2023 | 1198 | 0.200 |
Why?
|
Adult | 43 | 2024 | 221177 | 0.190 |
Why?
|
Phosphorylation | 7 | 2023 | 8320 | 0.190 |
Why?
|
Receptors, GABA-A | 1 | 2005 | 623 | 0.180 |
Why?
|
Genetic Vectors | 2 | 2007 | 3395 | 0.170 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2024 | 620 | 0.170 |
Why?
|
Promoter Regions, Genetic | 3 | 2009 | 5789 | 0.170 |
Why?
|
Radiopharmaceuticals | 3 | 2018 | 2651 | 0.170 |
Why?
|
Cerebrospinal Fluid | 1 | 2022 | 544 | 0.170 |
Why?
|
Synaptic Transmission | 1 | 2005 | 1173 | 0.160 |
Why?
|
TDP-43 Proteinopathies | 1 | 2018 | 38 | 0.150 |
Why?
|
Atlases as Topic | 1 | 2019 | 248 | 0.150 |
Why?
|
Inheritance Patterns | 1 | 2020 | 341 | 0.150 |
Why?
|
Apathy | 1 | 2019 | 107 | 0.150 |
Why?
|
Corpus Striatum | 2 | 2018 | 1235 | 0.150 |
Why?
|
alpha-Synuclein | 1 | 2024 | 750 | 0.150 |
Why?
|
Dementia | 2 | 2022 | 2686 | 0.140 |
Why?
|
Rats, Sprague-Dawley | 6 | 2009 | 8181 | 0.140 |
Why?
|
Lymphatic Vessels | 1 | 2021 | 358 | 0.140 |
Why?
|
Seizures | 2 | 2020 | 2957 | 0.140 |
Why?
|
Resilience, Psychological | 1 | 2024 | 788 | 0.130 |
Why?
|
Family Health | 2 | 2018 | 1257 | 0.130 |
Why?
|
Cerebral Hemorrhage | 3 | 2023 | 2656 | 0.130 |
Why?
|
Mental Status Schedule | 1 | 2016 | 314 | 0.130 |
Why?
|
Avoidance Learning | 2 | 2007 | 248 | 0.120 |
Why?
|
Central Nervous System | 1 | 2022 | 1336 | 0.120 |
Why?
|
Diagnostic Self Evaluation | 1 | 2017 | 224 | 0.120 |
Why?
|
Risk | 4 | 2020 | 9610 | 0.120 |
Why?
|
Valine | 1 | 2016 | 408 | 0.120 |
Why?
|
Rats | 7 | 2009 | 23742 | 0.120 |
Why?
|
Methionine | 1 | 2016 | 572 | 0.110 |
Why?
|
Cerebrovascular Circulation | 1 | 2024 | 2727 | 0.110 |
Why?
|
Activities of Daily Living | 2 | 2023 | 2421 | 0.110 |
Why?
|
Models, Neurological | 2 | 2020 | 1767 | 0.110 |
Why?
|
Green Fluorescent Proteins | 3 | 2009 | 2065 | 0.110 |
Why?
|
Double-Blind Method | 2 | 2024 | 12341 | 0.100 |
Why?
|
Neuropsychological Tests | 4 | 2019 | 7045 | 0.100 |
Why?
|
Sex Characteristics | 2 | 2023 | 2639 | 0.100 |
Why?
|
Microglia | 1 | 2021 | 1361 | 0.100 |
Why?
|
Anxiety | 1 | 2007 | 4573 | 0.100 |
Why?
|
RNA, Messenger | 6 | 2019 | 12795 | 0.100 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4414 | 0.100 |
Why?
|
Carrier Proteins | 1 | 2005 | 4936 | 0.100 |
Why?
|
Linear Models | 2 | 2019 | 5871 | 0.100 |
Why?
|
Diffusion Tensor Imaging | 4 | 2024 | 2400 | 0.090 |
Why?
|
Functional Laterality | 1 | 2018 | 2257 | 0.090 |
Why?
|
Neurogranin | 2 | 2022 | 15 | 0.090 |
Why?
|
Transduction, Genetic | 2 | 2018 | 903 | 0.090 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2013 | 277 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2735 | 0.080 |
Why?
|
Pentagastrin | 1 | 2008 | 17 | 0.080 |
Why?
|
Contrast Media | 2 | 2019 | 5311 | 0.080 |
Why?
|
Piperidines | 2 | 2008 | 1656 | 0.080 |
Why?
|
Geriatric Assessment | 1 | 2016 | 1410 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 4 | 2021 | 17904 | 0.080 |
Why?
|
Immunoassay | 2 | 2022 | 745 | 0.080 |
Why?
|
Fibroblasts | 1 | 2018 | 4141 | 0.070 |
Why?
|
Membrane Proteins | 1 | 2005 | 7856 | 0.070 |
Why?
|
Exercise | 1 | 2024 | 5890 | 0.070 |
Why?
|
Internationality | 1 | 2013 | 1001 | 0.070 |
Why?
|
Macrophages | 1 | 2022 | 5769 | 0.070 |
Why?
|
Alleles | 1 | 2019 | 6863 | 0.070 |
Why?
|
Animals | 14 | 2023 | 168459 | 0.070 |
Why?
|
Cohort Studies | 8 | 2024 | 41487 | 0.070 |
Why?
|
Electrophysiological Phenomena | 1 | 2009 | 307 | 0.070 |
Why?
|
Rest | 1 | 2012 | 918 | 0.070 |
Why?
|
Spatial Behavior | 1 | 2007 | 88 | 0.070 |
Why?
|
Pyrazoles | 2 | 2008 | 2009 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2018 | 3575 | 0.070 |
Why?
|
Receptor, PAR-1 | 1 | 2007 | 109 | 0.070 |
Why?
|
Transfection | 2 | 2018 | 5774 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39106 | 0.060 |
Why?
|
Association Learning | 1 | 2007 | 221 | 0.060 |
Why?
|
Receptor, trkB | 1 | 2006 | 124 | 0.060 |
Why?
|
Flunitrazepam | 1 | 2005 | 20 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3522 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4652 | 0.060 |
Why?
|
Maze Learning | 1 | 2007 | 483 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4016 | 0.060 |
Why?
|
Epilepsy | 1 | 2020 | 3290 | 0.060 |
Why?
|
GABA-A Receptor Agonists | 1 | 2005 | 86 | 0.060 |
Why?
|
Asymptomatic Diseases | 2 | 2019 | 588 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 9000 | 0.060 |
Why?
|
Integrases | 1 | 2007 | 516 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2022 | 9539 | 0.060 |
Why?
|
Mice | 8 | 2023 | 81525 | 0.060 |
Why?
|
Interneurons | 1 | 2009 | 593 | 0.060 |
Why?
|
Fluorine Radioisotopes | 2 | 2017 | 418 | 0.060 |
Why?
|
Gene Expression | 2 | 2007 | 7581 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9420 | 0.050 |
Why?
|
Transgenes | 1 | 2007 | 1010 | 0.050 |
Why?
|
Phobic Disorders | 1 | 2006 | 439 | 0.050 |
Why?
|
Threonine | 1 | 2023 | 271 | 0.050 |
Why?
|
Signal Transduction | 1 | 2006 | 23445 | 0.050 |
Why?
|
Genes, Reporter | 1 | 2007 | 1529 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2023 | 172 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2017 | 6019 | 0.050 |
Why?
|
Organ Size | 2 | 2018 | 2254 | 0.050 |
Why?
|
Prognosis | 3 | 2017 | 29625 | 0.050 |
Why?
|
Benzodiazepines | 1 | 2008 | 1132 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 12953 | 0.050 |
Why?
|
Proline | 1 | 2023 | 457 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2018 | 2850 | 0.050 |
Why?
|
Risk Factors | 5 | 2023 | 74206 | 0.050 |
Why?
|
Adolescent | 5 | 2022 | 88319 | 0.050 |
Why?
|
Rheology | 1 | 2022 | 347 | 0.050 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1900 | 0.050 |
Why?
|
Genetic Engineering | 1 | 2007 | 933 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2022 | 553 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2021 | 127 | 0.050 |
Why?
|
Gliosis | 1 | 2021 | 245 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3429 | 0.040 |
Why?
|
Neurocalcin | 1 | 2019 | 3 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2007 | 2645 | 0.040 |
Why?
|
Calibration | 1 | 2022 | 818 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 983 | 0.040 |
Why?
|
Synaptosomal-Associated Protein 25 | 1 | 2019 | 51 | 0.040 |
Why?
|
Life Change Events | 1 | 2024 | 952 | 0.040 |
Why?
|
Phencyclidine | 1 | 1998 | 60 | 0.040 |
Why?
|
Neurologic Examination | 1 | 2022 | 916 | 0.040 |
Why?
|
Learning | 1 | 2008 | 1740 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2021 | 584 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 829 | 0.040 |
Why?
|
Endocytosis | 1 | 2022 | 957 | 0.040 |
Why?
|
Hemorrhage | 2 | 2022 | 3424 | 0.040 |
Why?
|
Solubility | 1 | 2020 | 1091 | 0.040 |
Why?
|
Behavior, Animal | 1 | 2006 | 1878 | 0.040 |
Why?
|
Sclerosis | 1 | 2018 | 210 | 0.040 |
Why?
|
Neurofibrillary Tangles | 1 | 2020 | 457 | 0.040 |
Why?
|
Encephalitis | 1 | 2021 | 438 | 0.040 |
Why?
|
Myelin Sheath | 1 | 2021 | 653 | 0.040 |
Why?
|
Thiones | 1 | 2017 | 46 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23995 | 0.040 |
Why?
|
Blood Pressure | 2 | 2023 | 8481 | 0.040 |
Why?
|
Microtubules | 1 | 2023 | 1074 | 0.040 |
Why?
|
Information Services | 1 | 2018 | 236 | 0.040 |
Why?
|
Palmitates | 1 | 2017 | 70 | 0.040 |
Why?
|
Depression | 1 | 2017 | 8124 | 0.030 |
Why?
|
Phagocytosis | 1 | 2022 | 1528 | 0.030 |
Why?
|
Inflammation | 3 | 2022 | 10773 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1188 | 0.030 |
Why?
|
Acetylcholine | 1 | 1998 | 629 | 0.030 |
Why?
|
Karyotyping | 1 | 2018 | 1171 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 1998 | 448 | 0.030 |
Why?
|
Benzothiazoles | 1 | 2017 | 247 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15732 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2022 | 20098 | 0.030 |
Why?
|
Disclosure | 1 | 2022 | 748 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 641 | 0.030 |
Why?
|
Age Factors | 3 | 2020 | 18395 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15842 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10552 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2022 | 3162 | 0.030 |
Why?
|
ROC Curve | 1 | 2022 | 3579 | 0.030 |
Why?
|
Autophagy | 1 | 2021 | 1326 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54425 | 0.030 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1998 | 894 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 59243 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 4063 | 0.030 |
Why?
|
Life Style | 1 | 2024 | 3917 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11076 | 0.030 |
Why?
|
Haplotypes | 1 | 2018 | 2713 | 0.020 |
Why?
|
Pedigree | 1 | 2019 | 4542 | 0.020 |
Why?
|
International Cooperation | 1 | 2018 | 1422 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2020 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22176 | 0.020 |
Why?
|
Dopamine | 1 | 1998 | 1607 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2023 | 3065 | 0.020 |
Why?
|
Peptides | 1 | 2023 | 4358 | 0.020 |
Why?
|
Time Factors | 2 | 2017 | 39967 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2018 | 1881 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2141 | 0.020 |
Why?
|
Neuroblastoma | 1 | 2018 | 1250 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4111 | 0.020 |
Why?
|
Titrimetry | 1 | 2009 | 35 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15936 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2790 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2018 | 2093 | 0.020 |
Why?
|
Prefrontal Cortex | 1 | 1998 | 2219 | 0.020 |
Why?
|
Biophysical Phenomena | 1 | 2009 | 320 | 0.020 |
Why?
|
Biophysics | 1 | 2009 | 380 | 0.020 |
Why?
|
Cost of Illness | 1 | 2017 | 1936 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7594 | 0.020 |
Why?
|
Brain Concussion | 1 | 2018 | 1404 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2018 | 1860 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2009 | 927 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3518 | 0.020 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2006 | 144 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16591 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2009 | 1090 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3357 | 0.020 |
Why?
|
Receptors, Glutamate | 1 | 2006 | 228 | 0.020 |
Why?
|
Electroencephalography | 1 | 2020 | 6225 | 0.020 |
Why?
|
Regression Analysis | 1 | 2014 | 6343 | 0.010 |
Why?
|
Lysine | 1 | 2009 | 993 | 0.010 |
Why?
|
Motor Skills | 1 | 2007 | 521 | 0.010 |
Why?
|
Plasmids | 1 | 2009 | 2269 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13255 | 0.010 |
Why?
|
Gene Targeting | 1 | 2007 | 838 | 0.010 |
Why?
|
MicroRNAs | 1 | 2019 | 3816 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8631 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7967 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8830 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15266 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12463 | 0.010 |
Why?
|
Cues | 1 | 2007 | 875 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2009 | 2707 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18252 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16981 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2007 | 14414 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 80636 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2006 | 1176 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8002 | 0.010 |
Why?
|
Gene Deletion | 1 | 2007 | 2665 | 0.010 |
Why?
|
Microdialysis | 1 | 1998 | 161 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14031 | 0.010 |
Why?
|
Motor Activity | 1 | 2007 | 2715 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20570 | 0.010 |
Why?
|
Psychotherapy | 1 | 2006 | 1647 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15601 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 18965 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22169 | 0.000 |
Why?
|